We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.72B
AUM Growth
-$277M
Cap. Flow
-$598M
Cap. Flow %
-7.74%
Top 10 Hldgs %
14.2%
Holding
2,837
New
108
Increased
534
Reduced
1,798
Closed
392

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32M
2
MSFT icon
Microsoft
MSFT
+$15.3M
3
GILD icon
Gilead Sciences
GILD
+$12.4M
4
AMGN icon
Amgen
AMGN
+$10.3M
5
CELG
Celgene Corp
CELG
+$9.92M

Sector Composition

Rank Sector Weight
1 Financials 17.01%
2 Technology 15.04%
3 Healthcare 13.56%
4 Industrials 9.01%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
51
Caterpillar
CAT
$405B
$24.9M 0.32%
229,480
+10,444
+5% +$1.1M
AMT icon
52
American Tower
AMT
$79.2B
$23.2M 0.3%
258,137
-16,049
-6% -$1.39M
EBAY icon
53
eBay
EBAY
$49.8B
$23M 0.3%
1,089,562
-114,134
-9% -$2.49M
TRV icon
54
Travelers Companies
TRV
$78.5B
$23M 0.3%
244,028
+9,135
+4% +$833K
TXN icon
55
Texas Instruments
TXN
$258B
$22.9M 0.3%
479,577
-48,834
-9% -$2.28M
BKNG icon
56
Booking.com
BKNG
$141B
$22.9M 0.3%
475,925
-56,775
-11% -$2.72M
MDLZ icon
57
Mondelez International
MDLZ
$78.3B
$22.8M 0.3%
606,467
-95,598
-14% -$3.49M
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$123B
$22.3M 0.29%
235,869
-50,171
-18% -$3.52M
ABBV icon
59
AbbVie
ABBV
$450B
$22.3M 0.29%
395,393
+14,481
+4% +$760K
MET icon
60
MetLife
MET
$60.5B
$22M 0.28%
443,315
-23,303
-5% -$1.09M
PM icon
61
Philip Morris
PM
$301B
$21.6M 0.28%
256,567
-28,046
-10% -$2.41M
ESRX
62
DELISTED
Express Scripts Holding Company
ESRX
$21.1M 0.27%
303,645
-37,577
-11% -$2.64M
TFCFA
63
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$21M 0.27%
596,557
-89,648
-13% -$3.05M
SBUX icon
64
Starbucks
SBUX
$120B
$20.9M 0.27%
539,784
-76,082
-12% -$2.76M
REGN icon
65
Regeneron Pharmaceuticals
REGN
$70.9B
$19.6M 0.25%
69,348
-13,827
-17% -$4.1M
DD icon
66
DuPont de Nemours
DD
$18.3B
$19.5M 0.25%
149,561
-3,153
-2% -$402K
NKE icon
67
Nike
NKE
$64.9B
$18.9M 0.25%
488,216
+11,052
+2% +$411K
MON
68
DELISTED
Monsanto Co
MON
$18.6M 0.24%
149,293
-7,875
-5% -$922K
COST icon
69
Costco
COST
$417B
$18.6M 0.24%
161,401
-21,096
-12% -$2.42M
VTRS icon
70
Viatris
VTRS
$20.1B
$18.1M 0.23%
350,774
-68,952
-16% -$3.39M
ADP icon
71
Automatic Data Processing
ADP
$102B
$18M 0.23%
258,999
+2,978
+1% +$203K
PNC icon
72
PNC Financial Services
PNC
$101B
$17.9M 0.23%
200,943
-8,037
-4% -$686K
OXY icon
73
Occidental Petroleum
OXY
$54.6B
$17.7M 0.23%
180,471
-7,776
-4% -$731K
DOC icon
74
Healthpeak Properties
DOC
$15.5B
$17.6M 0.23%
466,827
+30,619
+7% +$1.15M
CCI icon
75
Crown Castle
CCI
$34.6B
$17.5M 0.23%
235,787
+2,793
+1% +$209K

Similar funds

ProShare Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, ProShare Advisors held 2,837 positions worth $7.72B, down 3.5% from $8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors withdrew a net $598M in Q2 2014, closing 392 positions and reducing 1,798 holdings. Its most notable exit was CoStar Group, an estimated $5.45M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, ProShare Advisors opened a new position in Navient worth $3.44M.

  • ProShare Advisors's largest Q2 2014 buy was Navient: 194,061 shares worth $3.44M.
  • ProShare Advisors added most to Affiliated Managers Group in Q2 2014, an estimated $3.87M increase.
  • ProShare Advisors's biggest Q2 2014 reduction was Apple, cutting an estimated $32M.
  • ProShare Advisors fully exited CoStar Group in Q2 2014, selling an estimated $5.45M.
  • ProShare Advisors's ten largest holdings make up 14% of its $7.72B portfolio in Q2 2014.
  • ProShare Advisors opened 108 new positions and closed 392 in Q2 2014.
  • ProShare Advisors's portfolio value fell 3.5% quarter-over-quarter to $7.72B.

Based on ProShare Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.